NASDAQ:CLRB
Cellectar Biosciences, Inc.
- Stock
Last Close
3.43
06/11 22:11
Market Cap
84.24M
Beta: 1.17
Volume Today
359.90K
Avg: 55.21K
PE Ratio
−1.03
PFCF: −1.36
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||||
average payables | 306K - | 945K 208.82% | 1.35M 43.23% | 1.42M 5.06% | 1.99M 39.70% | 1.28M 35.62% | |||||
average receivables | |||||||||||
book value per share | 2.34K - | 211.00 90.98% | 310.08 46.96% | 76.65 75.28% | 44.77 41.59% | 11.80 73.64% | 27.66 134.30% | 5.95 78.48% | 2.20 63.08% | -110.96K 5,048,378.87% | |
capex per share | -6.44 - | -7.48 16.13% | -1.65 77.87% | -2.47 49.33% | -1.30 47.40% | -0.03 97.54% | -0.03 1.58% | -0.03 19.09% | -0.03 25.78% | -70.70K 220,744,990.22% | |
capex to depreciation | -0.08 - | -0.16 100.30% | -0.20 25.59% | -0.22 10.70% | -4.68 1,986.91% | -0.18 96.05% | -0.44 138.52% | -0.94 113.91% | -1.52 61.45% | -4.49 195.03% | |
capex to operating cash flow | 0.00 - | 0.01 112.85% | 0.01 22.54% | 0.03 260.63% | 0.03 6.95% | 0.00 93.76% | 0.00 113.24% | 0.01 39.96% | 0.01 43.04% | 0.02 172.58% | |
capex to revenue | |||||||||||
cash per share | 2.05K - | 493.39 75.96% | 262.09 46.88% | 71.31 72.79% | 44.75 37.25% | 13.83 69.10% | 28.85 108.62% | 6.43 77.71% | 2.82 56.22% | 782.63K 27,795,566.33% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.03 - | 0.04 29.89% | 0.01 86.24% | 0.00 93.39% | 0.00 63.95% | 0.04 29,192.36% | 0.01 83.31% | 0.01 12.84% | 0.03 244.82% | 0.05 63.73% | |
debt to equity | 0.04 - | 0.21 378.90% | 0.01 96.62% | 0.00 93.01% | 0.00 65.81% | 0.06 34,793.14% | 0.01 86.79% | 0.01 18.66% | 0.04 326.43% | -0.41 1,147.29% | |
dividend yield | 0.08 - | 0.49 547.81% | |||||||||
earnings yield | -0.57 - | -0.95 66.23% | -1.16 22.16% | -0.71 39.19% | -2.88 308.72% | -0.80 72.14% | -0.36 55.43% | -0.65 82.70% | -2.37 262.36% | -1.12M 47,329,966.92% | |
enterprise value | 5.23M - | 2.27M 56.62% | -6.02M 365.45% | 9.22M 253.11% | -8.66M 193.93% | 7.18M 182.91% | -15.53M 316.29% | 1.24M 107.97% | -7.20M 681.30% | -9.01M 25.21% | |
enterprise value over ebitda | -0.46 - | -0.20 57.75% | 0.49 349.54% | -0.76 256.63% | 0.87 213.90% | -0.50 158.06% | 1.00 298.76% | -0.05 105.11% | 0.25 586.84% | 0.23 7.40% | |
ev to operating cash flow | -0.59 - | -0.28 53.30% | 0.73 363.23% | -0.84 215.07% | 0.76 190.47% | -0.61 181.12% | 1.11 281.53% | -0.05 104.92% | 0.29 620.15% | 0.25 10.74% | |
ev to sales | |||||||||||
free cash flow per share | -1.93K - | -1.06K 45.23% | -191.33 81.91% | -81.01 57.66% | -39.93 50.71% | -15.27 61.76% | -7.06 53.73% | -4.09 42.09% | -3.61 11.83% | -2.97M 82,224,009.32% | |
free cash flow yield | -0.63 - | -1.43 128.68% | -1.57 9.70% | -0.59 62.29% | -2.58 335.65% | -0.68 73.66% | -0.34 49.95% | -0.62 82.51% | -2.11 240.30% | -1.07M 50,759,187.70% | |
graham net net | 1.47K - | -267.14 118.18% | 221.22 182.81% | 56.23 74.58% | 38.70 31.17% | 9.67 75.01% | 26.90 178.15% | 5.68 78.88% | 1.95 65.62% | -316.38K 16,194,562.53% | |
graham number | 9.64K - | 1.83K 81.05% | 993.71 45.60% | 408.28 58.91% | 212.19 48.03% | 69.29 67.35% | 68.08 1.75% | 24.05 64.68% | 14.16 41.12% | 2.79M 19,673,419.38% | |
income quality | 1.09 - | 1.49 37.05% | 1.34 10.34% | 0.81 39.36% | 0.86 6.36% | 0.83 3.99% | 0.92 11.24% | 0.94 1.36% | 0.88 5.74% | 0.93 5.63% | |
intangibles to total assets | 0.12 - | 0.22 76.66% | 0.11 50.43% | 0.13 19.06% | 0 100% | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 22.16 - | 10.41K 46,889.95% | -1.20K 111.49% | -819.09 31.55% | -449.04 45.18% | 95.74 - | |||||
interest debt per share | 3.70 - | 43.46 1,074.45% | 2.35 94.60% | 0.16 93.36% | 0.11 30.85% | 0.69 538.19% | 0.21 69.04% | 0.05 74.46% | 0.04 21.02% | 45.25K 105,404,586.06% | |
inventory turnover | |||||||||||
invested capital | 0.04 - | 0.21 378.90% | 0.01 96.62% | 0.00 93.01% | 0.00 65.81% | 0.06 34,793.14% | 0.01 86.79% | 0.01 18.66% | 0.04 326.43% | -0.41 1,147.29% | |
market cap | 14.19M - | 5.79M 59.22% | 5.33M 7.93% | 19.22M 260.84% | 4.59M 76.12% | 17.27M 276.14% | 41.21M 138.64% | 36.64M 11.09% | 12.07M 67.07% | 33.85 100.00% | |
net current asset value | 7.02M - | -1.77M 125.14% | 10.41M 689.38% | 8.82M 15.24% | 12.16M 37.82% | 8.19M 32.61% | 54.07M 559.91% | 32.41M 40.06% | 14.45M 55.43% | -2.98M 120.62% | |
net debt to ebitda | 0.79 - | 0.30 61.77% | 0.92 203.37% | 0.83 9.86% | 1.33 60.69% | 0.71 46.70% | 3.67 416.95% | 1.47 59.99% | 0.67 54.43% | 0.23 65.40% | |
net income per share | -1.77K - | -702.78 60.19% | -141.54 79.86% | -96.66 31.71% | -44.70 53.76% | -18.08 59.56% | -7.45 58.80% | -4.32 42.03% | -4.05 6.12% | -3.11M 76,669,072.74% | |
operating cash flow per share | -1.93K - | -1.05K 45.44% | -189.67 81.94% | -78.54 58.59% | -38.63 50.82% | -15.24 60.56% | -7.03 53.84% | -4.07 42.19% | -3.57 12.07% | -2.89M 80,982,975.66% | |
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.69 - | -0.93 34.45% | -0.45 51.21% | -1.21 167.52% | -0.88 27.40% | -1.13 28.78% | -0.25 77.79% | -0.64 156.13% | -1.32 105.60% | -3.15 137.44% | |
revenue per share | |||||||||||
roe | -0.75 - | -3.33 341.52% | -0.46 86.30% | -1.26 176.28% | -1.00 20.83% | -1.53 53.40% | -0.27 82.42% | -0.73 169.35% | -1.84 154.26% | 28.01 1,618.72% | |
roic | -0.71 - | -1.65 132.13% | -0.33 80.25% | -1.26 286.16% | -0.89 29.60% | -1.38 55.60% | -0.27 80.53% | -0.71 165.24% | -1.72 141.39% | 155.55 9,142.27% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 2.34K - | 211.00 90.98% | 310.08 46.96% | 76.65 75.28% | 44.77 41.59% | 11.80 73.64% | 27.66 134.30% | 5.95 78.48% | 2.20 63.08% | -110.96K 5,048,378.87% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 9.07M - | -25.66K 100.28% | 11.86M 46,338.79% | 9.08M 23.48% | 13.26M 46.06% | 9.06M 31.68% | 54.79M 504.84% | 33.05M 39.69% | 15.51M 53.07% | -1.36M 108.74% | |
tangible book value per share | 1.98K - | -3.28 100.17% | 271.71 8,379.69% | 64.71 76.19% | 44.77 30.81% | 11.80 73.64% | 27.66 134.30% | 5.95 78.48% | 2.20 63.08% | -110.96K 5,048,378.87% | |
working capital | 7.51M - | -1.52M 120.26% | 10.56M 793.63% | 8.82M 16.44% | 12.33M 39.72% | 8.62M 30.12% | 54.38M 531.12% | 32.58M 40.08% | 15.00M 53.96% | -2.48M 116.56% |
All numbers in USD (except ratios and percentages)